Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future BOSTON–(BUSINESS WIRE)–#EY–Ernst & Young LLP (EY US) has named Nabiha Saklayen, Ph.D., CEO and Co-Founder of Cellino, a winner of the Entrepreneur Of The Year® 2025 New England Award. Now celebrating its 40th year, Entrepreneur Of The Year is one of the most … [Read more…]
FDA Investigational Device Exemption (IDE) Approval enables Presidio’s ULF platform technology to be tested in a pivotal clinical trial in the United States, representing a significant step in bringing this transformational technology to patients who suffer from chronic nociceptive low back pain. SAN MATEO, Calif.–(BUSINESS WIRE)–Presidio Medical, Inc., a global clinical-stage medical device company developing … [Read more…]
Innovative Agents Highlight Growth of Targeted Protein Degradation Platform and BMS’ Leadership in Innovative Cancer Therapies PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today announced the presentation of new data from its targeted protein degradation platform during the 2025 European Hematology Association (EHA) Annual Congress being held from June 12-15 in Milan, Italy. Presentations … [Read more…]
PARIS–(BUSINESS WIRE)–SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today announced the signature with SATT Conectus of an exclusive collaboration and worldwide license agreement for potent monoclonal antibodies targeting the BK virus. … [Read more…]
NEW YORK–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and … [Read more…]
(Securities Code: 4967 JT) *Oasis’s proposals at the EGM had over majority approval, when calculated on the basis of excluding the shares owned by the founding family and its related parties (Majority of Minority, “MoM”) *The Special Resolution (Agenda 1) at the AGM, which called for amendments to Kobayashi Pharma’s Articles of Incorporation, received supermajority … [Read more…]
Social services organizations can now join California’s largest nonprofit health data network to better coordinate whole person care with local hospitals and health plans RIVERSIDE, Calif.–(BUSINESS WIRE)–Manifest MedEx (MX) announced today that health-related social services (HRSS) organizations can now connect and exchange health and HRSS information through its nonprofit health data network to help those … [Read more…]
MAVYRET® (glecaprevir/pibrentasvir) is Now the Only Direct Acting Antiviral Therapy Approved to Treat Patients with Acute Hepatitis C Virus (HCV) in Eight Weeks with a 96% Cure Rate1*† FDA Approval Now Allows Providers to Treat HCV Patients Immediately at Time of Diagnosis If Left Untreated, Patients with Acute HCV Could Progress to Chronic Disease, Including … [Read more…]
Initiative includes General Catalyst, NVIDIA, Hippocratic AI, and Sword Health LONDON–(BUSINESS WIRE)–#GenAI–Guy’s and St Thomas’ NHS Foundation Trust has announced the launch of the Proactive & Accessible Transformation of Healthcare (PATH) initiative in collaboration with General Catalyst, NVIDIA, Hippocratic AI, and Sword Health. PATH brings together leading technology companies to explore comprehensive solutions to deliver … [Read more…]
Significantly more patients treated with Sotyktu achieved improvements in joint and skin symptoms, measures of disease activity and quality of life at Week 16 in POETYK PsA-1 New data from POETYK PsA-2 trial demonstrated that meaningful clinical responses continued to improve and outcomes were maintained through Week 52 Sotyktu demonstrated safety consistent with the established … [Read more…]
